The cancer fatigue syndrome -an overview;Das Cancer Fatigue Syndrom -eine Übersicht

Physikalische Medizin Rehabilitationsmedizin Kurortmedizin

Volumn 20, Issue 2, 2010, Pages 86-91

  Gutenbrunner, Ch ^a   Girke, M ^b,c   Dimeo, F ^d   Matthes, H ^b,c   Kroz M ^b,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Allgemein Internistische Abteilung des Gemeinschaftskrankenhauses Havelhöhe GGmbH   (Germany)

^c Gemeinschaftskrankenhaus Havelhohe   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cancer Related Fatigue (CRF); Insomnia; Multimodal therapy concepts; Rest activity rhythm

Indexed keywords

EID: 77951054017     PISSN: 09406689     EISSN: 1439085X     Source Type: Journal    
DOI: 10.1055/s-0029-1241854     Document Type: Article

References (50)

1. NCI. Fatigue (PDQ). U. S. National Institutes of Health Accessed 06/24/2009, 2009
2. Ahlberg K, Ekman T, Gaston-Johannson F, etal. Assessment and management of cancer-related fatigue in adults. Lancet 2003 362 640-650 (Pubitemid 37013308)
3. Hjermstad MJ, Fossa SD, Oldervoll L, etal. Fatigue in long-term Hodgkin's Disease survivors: A follow-up study. J Clin Oncol 2005 23 6587-6595 (Pubitemid 46190252)
4. Brach M, Cieza A, Stucki G, etal. ICF Core Sets for Breast Cancer. J Rehabil Med 2004 44 (Suppl.) 121-127 (Pubitemid 39307121)
5. Ryan JL, Carroll JK, Ryan EP, etal. Mechanisms of cancer-related fatigue. Oncologist 2007 12 22-34
6. Dimeo F, Schmittel A, Fietz T, etal. Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment. Ann Oncol 2004 15 1237-1242 (Pubitemid 39199311)
7. Stone P, Richardson A, Ream E, etal. Cancer-related fatigue: Inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol 2000 11 971-975
8. Hjermstad MJ, Fossa SD, Oldervoll L, etal. Fatigue in long-term Hodgkin's Disease survivors: A follow-up study. J Clin Oncol 2005 23 6587-6595 (Pubitemid 46190252)
9. Bower JE, Ganz PA, Desmond KA, etal. Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life. J Clin Oncol 2000 18 743-753 (Pubitemid 30106604)
10. Ahn SH, Park BW, Noh DY, etal. Health-related quality of life in disease-free survivors of breast cancer with the general population. Ann Oncol 2007 18 173-182 (Pubitemid 46152519)
11. Dittner A, Wessely S, Brown R. The assessment of fatigue. A practical guide for clinicans and researchers. J Psychosom Res 2004 56 157-170 (Pubitemid 38317466)
12. Glaus A, Muller S. Measuring fatigue of cancer patients in the German-speaking region: development of the Fatigue Assessment Questionnaire. Pflege 2001 14 161-170
13. Kröz M, Zerm R, Reif M, etal. Validation of a German version of the Cancer Fatigue Scale (CFS-D). European Journal of Cancer Care 2008 17 33-41
14. Radbruch L, Sabatowski R, Elsner F, etal. Validation of the German version of the brief fatigue inventory. J Pain Symptom Manage 2003 25 449-458 (Pubitemid 36506674)
15. McElroy JA, Newcomb PA, Titus-Ernstoff L, etal. Duration of sleep and breast cancer risk in a large population-based case-control study. J Sleep Res 2006 15 241-249 (Pubitemid 44215540)
16. Niemann H, Maschke C. WHO LARES Final report Noise effects and morbidity. WHO 2004
17. Davidson JR, MacLean AW, Brundage MD, etal. Sleep disturbance in cancer patients. Soc Sci Med 2002 54 1309-1321
18. Roscoe JA, Morrow GR, Hickok JT, etal. Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer 2002 10 329-336
19. Mormont MC, Waterhouse J, Bleuzen P, etal. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 2000 6 3038-3045 (Pubitemid 30637726)
20. Innominato PF, Focan C, Gorlia T, etal. Circadian rhythm in rest and activity: A biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res 2009 69 4700-4707
21. Silberfarb PM, Hauri PJ, Oxman TE, etal. Assessment of sleep in patients with lung cancer and breast cancer. J Clin Oncol 1993 11 997-1004 (Pubitemid 23146099)
22. Leining MG, Gelber S, Rosenberg R, etal. Menopausal-type symptoms in young breast cancer survivors. Ann Oncol 2006 17 1777-1782 (Pubitemid 44884052)
23. Bower JE, Ganz PA, Desmond KA, etal. Fatigue in long-term breast carcinoma survivors: A longitudinal investigation. Cancer 2006 106 751-758
24. Servaes P, Prins J, Verhagen S, etal. Fatigue after breast cancer and in chronic fatigue syndrome: Similarities and differences. J Psychosom Res 2002 52 453-459 (Pubitemid 34752339)
25. Poppelreuter M, Weis J, Schmid J, etal. Neuropsychologische Folgestörungen nach adjuvanter Therapie des Mammakarzinoms. Onkologie 2006 12 27-35
26. Matsuda T, Takayama T, Tashiro M, etal. Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients evaluation of appropriate research design and methodology to measure symptoms. Breast Cancer 2005 12 279-287
27. Fan HG, Houede-Tchen N, Yi QL, etal. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 2005 23 8025-8032 (Pubitemid 46657404)
28. Ahles TA, Saykin AJ. Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer 2002 3 S84-90
29. Groenvold M, Petersen MA, Idler E, etal. Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Res Treat 2007 105 209-219 (Pubitemid 47366885)
30. Hamann T, Hübner J, Neises M, etal. Studie über das subjektive Rehabilitationsbedürfnis von Patientinnen mit Mammakarzinom Vol 59 2005
31. Delbrück H. Krebsnachbehandlung. Berlin-Heidelberg Springer 2003
32. Hamann T. Das subjektive Rehabilitationsbedürfnis von Frauen mit Brustkrebs [Med.Inaug.Diss]. Hannover Institut für Physikalische Medizin, Medizinische Hochschule Hannover 2007
33. Hübner J. Lebensqualität und Symptome von Patientinnen mit Mammakarzinom Abschätzung und Entwicklung eines Rehabilitationsbedarfsscors. Hannover Klinik für Physikalische Medizin, Medizinische Hochschule Hannover 2009
34. Gutenbrunner C, Hübner J, Hamann T, etal. Rehabilitationsbedarf bei Patientinnen mit Mammakarzinom. Phys Med Rehab Kuror 2007 17 224-225
35. Aaronson N, The European Organisation for Research and Treatment of Cancer (EORTC). Modular Approach to Quality of Life. Assessment in Oncology. An Up-date. New York Raven Press 1994
36. Bullinger M. Erfassung der gesundheitsbezogenen Lebensqualität mit dem SF-36 Health Survey. Rehabilitation (Stuttg) 1996 35 XVII-XXX
37. Deck R, Kohlmann T, Raspe H. Erwartungen und Motivation bei Patienten in der medizinischen Rehabilitation. Z f Gesundheitspsychologie 1998 6 101-108
38. Muthny F. Wege der Krebsverarbeitung von Krebspatienten und Möglichkeiten von Hilfen. Bad Neuenahr (zit N Delbrück 2003) 1989
39. Herrmann C, Buss U. HADS-D, Hospital Anxiety and Depression Scale- Deutsche Version. Testdokumentation und Handanweisung. Bern, Göttingen, Toronto, Seattle Verlag Hans Huber 1995
40. Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001 37 1345-1351 (Pubitemid 32588744)
41. Carroll JK, Kohli S, Mustian KM, etal. Pharmacologic treatment of cancer-related fatigue. Oncologist 2007 12 43-51
42. Kallich JD, Tchekmedyian NS, Damiano AM, etal. Psychological outcomes associated with anemia-related fatigue in cancer patients. Oncology (Huntingt) 2002 16 (9 Suppl 10) 117-124
43. Straus DJ, Testa MA, Sarokhan BJ, etal. Quality-of-life and health benefits of early treatment of mild anemia: A randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies. Cancer 2006 107 1909-1917
44. Bohlius J, Schmidlin K, Brillant C, etal. Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: A meta-analysis of randomised trials. Lancet 2009 373 1532-1542
45. Dimeo FC, Stieglitz RD, Novelli-Fischer U, etal. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer 1999 85 2273-2277 (Pubitemid 29215569)
46. Spiegel D, Bloom JR, Kraemer HC, etal. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989 2 888-891 (Pubitemid 19245291)
47. Carlson LE, Ursuliak Z, Goodey E, etal. The effects of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients: 6-month follow-up. Support Care Cancer 2001 9 112-123 (Pubitemid 32246458)
48. Bruera E, Valero V, Driver L, etal. Patient-controlled methylphenidate for cancer fatigue: A double-blind, randomized, placebo-controlled trial. J Clin Oncol 2006 24 2073-2078
49. Piao BK, Wang YX, Xie GR, etal. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. Anticancer Res 2004 24 303-309
50. Semiglazov VF, Stepula VV, Dudov A, etal. Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: A randomised, placebo-controlled, double-blind, multicentre clinical trial. Anticancer Res 2006 26 1519-1529